Event-Driven Stocks

Nuwellis, Inc.

NUWENasdaq

Healthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs1 good4 warning1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$8.3M$8.7M$8.9M$8.5M$7.9M$7.4M
Operating income−$11.1M−$11.0M−$17.6M−$17.2M−$19.5M−$17.0M
Net income−$17.5M−$11.2M−$20.2M−$14.5M−$19.6M−$15.8M
Total assets$6.1M$9.9M$9.8M$24.7M$30.4M$20.0M
Total liabilities$3.5M$3.3M$6.6M$12.3M$4.5M$3.7M
Equity$2.6M$6.5M$3.0M$12.4M$25.9M$16.3M
EPS (diluted)$-25.39$-353.30$-360.06$-83.55$-285.36$-10.67
Shares out.4.4M6.8M1.2M10.5M6.5M20.8M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−134.3%
Net margin
−211.9%
Return on equity
−667.7%
Return on assets
−286.4%
Return on capital (ROCE)
−359.9%
Liabilities / assets
57.0%
Debt / equity
1.33×
Book value / share
$0.60
Revenue growth (YoY)
−5.4%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-177.65distress
Accruals / assets
109.7%clean
Beneish M-Score
-7.65normal
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
42
/ 100
Profitability 0Growth 0Catalyst 67Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

1 severe4 warning1 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202635,3551.0-49.6%
Apr 30, 202670,2181.9+41.0%
Apr 15, 202649,7961.3+57.0%
Mar 31, 202631,7141.0+6.4%
Mar 13, 202629,8151.0+6.1%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)